Skip to main content
. 2021 Mar 26;16(4):552–559. doi: 10.2215/CJN.12480720

Table 1.

Baseline characteristics by Fried frailty criteria of participants in the Canadian Frailty Observation and Interventions Trial

Variable Not Frail Frail
N 399 204
Demographics
 Agea 66 (54–73) 73 (65–82)
 Sex (% women)b 144 (36) 103 (51)
 Race (% White)b 326 (82) 163 (80)
Clinical measurementsa
 Systolic BP, mm Hg 136 (124–149) 138 (123–153)
 Diastolic BP, mm Hg 75 (67–83) 70 (63–80)
 Weight, kg 86 (72–101) 81 (70–92)
 Creatinine, mg/dl 3.05 (2.25–4.01) 3.06 (2.26–3.96)
 eGFR, ml/min per 1.73 m2 19 (13–25) 18 (13–24)
 Hemoglobin, g/dl 11.6 (10.7–12.7) 11.1 (10.1–12.2)
 Serum albumin, g/dl 3.6 (3.3–3.9) 3.5 (3.2–3.8)
 Serum phosphate, mg/dl 4.1 (3.5–4.7) 4.3 (3.7–4.9)
 Urine ACR, mg/gc 51 (7–173) 71 (9–237)
 HbA1c, %c 6.2 (5.6–7.5) 6.3 (5.7–7.6)
Comorbiditiesb
 Previous MI (%) 80 (20) 43 (22)
 Diabetes, type 1 or 2 (%) 209 (52) 135 (66)
 Peripheral vascular disease (%) 31 (8) 44 (22)
 Gastrointestinal disease (%) 71 (18) 47 (24)
 Malignancy (%) 81 (20) 41 (20)
 COPD (%) 22 (6) 24 (12)
 Hypertension (%) 336 (84) 187 (92)
 Arthritis (%) 138 (35) 108 (53)
 Congestive heart failure (%) 32 (8) 35 (17)
 Depression (%) 59 (15) 42 (21)
 Visual/hearing impairment (%) 196 (49) 138 (68)
 Neurologic disease (%) 36 (9) 53 (26)
 Comorbidity indexa 3 (2–4) 4 (3–5)
CKD stage at enrollmentb (% stage 5)
 CKD stage 115 (28.8) 63 (30.9)
Median kidney failure risk,c %
 5-yr risk 21 21

ACR, albumin-to-creatinine ratio; HbA1c, hemoglobin A1c; MI, myocardial infarction; COPD, chronic obstructive pulmonary disease.

a

Continuous variables are reported as medians and interquartile ranges. Mann–Whitney U test was used to compare continuous variables.

b

Categorical variables are reported as percentages and compared using chi-squared tests.

c

Variables are reported in complete cases (urine ACR missing =27%, HbA1c missing =35%).